A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care model, which is characterized by low-threshold, nonstigmatizing care colocated in a syringe service program, is more effective than the usual care model, […]
CHASING COVID Cohort study, T5K study profile, grand rounds with implementation science pioneer Enola Proctor, ISPH in the news, and more
Accessible Care study, New Metrics for Ending the HIV Epidemic, Policy Tracker on the Ending the Epidemic Dashboard, and more.
For immediate release Hepatitis C infection (HCV) prevalence in the United States (US) is highest among people who inject drugs (PWID), yet this population is rarely offered antiviral treatment. New antiviral treatment regimens are nearly 100% effective at curing HCV, but few studies have addressed the new regimen’s efficacy among PWID. A randomized controlled trial […]